Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$616M |
| 2 |
Netflix
NFLX
|
+$481M |
| 3 |
Micron Technology
MU
|
+$416M |
| 4 |
Tesla
TSLA
|
+$416M |
| 5 |
Procter & Gamble
PG
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$885M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$660M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$463M |
| 4 |
Applovin
APP
|
+$430M |
| 5 |
Meta Platforms (Facebook)
META
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.84% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.86% |
| 4 | Industrials | 9.95% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
10x Genomics
TXG
$10.1B
| $25.3M | 0.04% |
1,550,539
+505,618
| +48% | +$7.64M |
2024 Q4
4 quarters
|
|
502
Core Scientific
CORZ
$4.94B
| $25.2M | 0.04% |
1,730,463
+175,177
| +11% | +$3.05M |
2024 Q2
6 quarters
|
|
503
Dollar Tree
DLTR
$22.3B
| $25.2M | 0.04% |
204,703
-937,600
| -82% | -$100M |
2024 Q1
7 quarters
|
|
504
MasterBrand
MBC
$1.41B
| $25.1M | 0.04% |
2,271,863
+158,500
| +7% | +$1.86M |
2022 Q4
12 quarters
|
|
505
Genpact
G
$5.8B
| $25.1M | 0.04% |
536,000
+4,000
| +0.8% | +$173K |
2023 Q4
8 quarters
|
|
506
Liberty Media Corporation Series A Common Stock
FWONA
$22B
| $25.1M | 0.04% |
280,522
-38,500
| -12% | -$3.45M |
2014 Q4
44 quarters
|
|
507
Protolabs
PRLB
$2.21B
| $25M | 0.04% |
493,551
-50,100
| -9% | -$2.56M |
2021 Q1
19 quarters
|
|
508
Sarepta Therapeutics
SRPT
$1.92B
| $25M | 0.04% |
1,159,578
-1,490,600
| -56% | -$31.4M |
2025 Q2
2 quarters
|
|
509
TechnipFMC
FTI
$27.3B
| $24.9M | 0.04% |
558,500
-369,900
| -40% | -$15.6M |
2023 Q4
8 quarters
|
|
510
ANI Pharmaceuticals
ANIP
$1.65B
| $24.8M | 0.04% |
314,402
+41,500
| +15% | +$3.59M |
2023 Q2
10 quarters
|
|
511
Carpenter Technology
CRS
$19.2B
| $24.8M | 0.04% |
78,800
-53,600
| -40% | -$16.1M |
2024 Q2
6 quarters
|
|
512
Warner Music
WMG
$15.1B
| $24.8M | 0.04% |
808,222
-335,378
| -29% | -$10.2M |
2025 Q1
3 quarters
|
|
513
Solventum
SOLV
$14.7B
| $24.8M | 0.04% |
312,800
+161,000
| +106% | +$12.3M |
2025 Q1
3 quarters
|
|
514
Performance Food Group
PFGC
$14.9B
| $24.8M | 0.04% |
275,307
-172,700
| -39% | -$16.7M |
2024 Q3
5 quarters
|
|
515
Ennis
EBF
$576M
| $24.6M | 0.04% |
1,368,146
-93,800
| -6% | -$1.64M |
2015 Q1
43 quarters
|
|
516
Calix
CALX
$2.27B
| $24.5M | 0.04% |
463,618
+202,800
| +78% | +$11.8M |
2013 Q2
50 quarters
|
|
517
Myers Industries
MYE
$1.15B
| $24.5M | 0.04% |
1,308,590
-20,407
| -2% | -$362K |
2015 Q4
40 quarters
|
|
518
OneSpaWorld
OSW
$2.39B
| $24.5M | 0.04% |
1,180,340
-91,300
| -7% | -$1.91M |
2022 Q1
15 quarters
|
|
519
Cogent Biosciences
COGT
$5.22B
| $24.5M | 0.04% |
689,068
+456,100
| +196% | +$12.8M |
2025 Q3
1 quarter
|
|
520
Veeva Systems
VEEV
$46.1B
| $24.5M | 0.04% |
109,640
-78,360
| -42% | -$20.8M |
2024 Q3
5 quarters
|
|
|
CDTX
521
DELISTED
Cidara Therapeutics
CDTX
| $24.4M | 0.04% |
110,560
+6,300
| +6% | +$1.02M |
2016 Q2
38 quarters
|
|
522
Zscaler
ZS
$35.4B
| $24.4M | 0.04% |
108,300
+2,800
| +3% | +$790K |
2022 Q1
15 quarters
|
|
523
Global Ship Lease
GSL
$1.64B
| $24.3M | 0.04% |
693,350
-145,200
| -17% | -$4.72M |
2023 Q4
8 quarters
|
|
524
Philip Morris
PM
$313B
| $24.2M | 0.04% |
+150,900
| New | +$23.4M |
2025 Q4
0 quarters
|
|
525
Badger Meter
BMI
$3.7B
| $24.1M | 0.04% |
138,400
-58,800
| -30% | -$10.6M |
2021 Q4
16 quarters
|
|
Similar funds
Renaissance Technologies's Q4 2025 Portfolio in Review
As of Q4 2025, Renaissance Technologies held 3,923 positions worth $64.5B, down 15% from $75.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $10.1B in Q4 2025, closing 736 positions and reducing 1,682 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $354M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in ServiceNow worth $204M.
- Renaissance Technologies's largest Q4 2025 buy was ServiceNow: 1,331,977 shares worth $204M.
- Renaissance Technologies added most to Costco in Q4 2025, an estimated $616M increase.
- Renaissance Technologies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $885M.
- Renaissance Technologies fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $354M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.5B portfolio in Q4 2025.
- Renaissance Technologies opened 466 new positions and closed 736 in Q4 2025.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $64.5B.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.